Dishman Carbogen Amcis Limited has informed the Exchange regarding Demise of Mr Janmejay R Vyas, Chairman of the company on May 27, 2025.
DCAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved in line with Nifty Microcap 250 and 0.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Dishman Carbogen Amcis Limited has informed the stock exchange about the passing away of Mr. Janmejay R Vyas, the Chairman of the company, on May 27, 2025. Mr. Vyas held the position of Chairman at the time of his demise. The company has notified the exchange about this leadership change due to the unfortunate event. The board and company will now need to address succession planning for the Chairman role.
The sudden loss of the Chairman could create short-term uncertainty around leadership and board continuity. Investors should watch for updates on interim arrangements and succession planning, which may influence governance stability and stock sentiment in the near term.